University of Oregon
Eugene, Oregon, 97403, United States
NCT Number: NCT05984966
This community-engaged project aims to improve the accessibility of rapid tests through a supported employment program for people who inject drugs (PWID). The overall goal is to develop a transformative community-driven intervention in partnership with a community partner to promote widespread access to rapid testing among PWID.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Eugene, Oregon, 97403, United States
The program is called Peer Connect2Test (PeerC2T). PWID will be recruited by a community partner who provides syringe exchange services. The community partner will train PWID to become peer health workers (PHW) to distribute SARS-CoV-2 rapid tests to other PWID. Investigators expect that PeerC2T will improve knowledge, self-efficacy, and health behaviors among PHWs.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
PeerC2T is part of a supported employment program where PWID are trained and supported to provide PWID with job skills to be able to act as Peer Health Workers to facilitate the distribution of rapid SARS-CoV-2 testing to other PWID. The effect of the training on the Peer Health Worker themself will be evaluated.
Other names: Peer Connect2Test
Time frame: Assessed at baseline and 3-month follow-up
Participant well-being was computed as the mean of eight items with a 7-point response option (1 = strongly disagree, 7 = strongly agree). The internal consistency, as measured with Cronbach's alpha (α), was .90, scores could range from 1 to 7, and higher scores indicated greater levels of well-being.
Time frame: Assessed at baseline and 3-month follow-up
Health communication self-efficacy was computed as the mean score of 14 items with a 5-point response option (1 = strongly disagree, 5 = strongly agree). The internal consistency, as measured with Cronbach's alpha (α), was .97; scores could range from 1 to 5, and higher scores indicated greater self-efficacy.
Time frame: Assessed at baseline and 3-month follow-up
Peer support self-efficacy, an Aim 1 measure, was computed as the mean score of 18 items with a 5-point response option (1 = not at all confident, 5 = very confident). The internal consistency, as measured with Cronbach's alpha (α), was .96; scores could range from 1 to 5, and higher scores indicated greater self-efficacy.
Time frame: Assessed at baseline and 3-month follow-up
COVID-19 knowledge was computed as the number of correctly endorsed items. Five items were presented to test knowledge of COVID-19. Scores could range from 0 to 5, and higher scores indicate greater levels of COVID-19 knowledge.
Time frame: Assessed at baseline and 3-month follow-up
HIV knowledge was computed as the number of correctly endorsed items. Four items were presented to test understanding of HIV. Scores could range from 0 to 4, and higher scores indicate greater levels of HIV knowledge.
Time frame: Assessed at baseline and 3-month follow-up
Hepatitis C knowledge was computed as the number of correctly endorsed items. Five items were presented to test understanding of HIV. Scores could range from 0 to 5, and higher scores indicate greater levels of hepatitis C knowledge.
Time frame: Assessed at baseline and 3-month follow-up
Syphilis knowledge was computed as the number of correctly endorsed items. Five items were presented to test understanding of HIV. Scores could range from 0 to 5, and higher scores indicate greater levels of Syphilis knowledge.
Time frame: Assessed at baseline and 3-month follow-up
Naloxone knowledge was computed as the number of correctly endorsed items. Five items were presented to test understanding of HIV. Scores could range from 0 to 5, and higher scores indicate greater levels of naloxone knowledge.
Time frame: Assessed at baseline and 3-month follow-up
Harm reduction risk behaviors included behaviors that occurred in the past month, and a higher score indicated greater levels of risky behavior. The injected drugs score was the total number of times a person reported they had injected drugs.
Time frame: Assessed at baseline and 3-month follow-up
Harm reduction risk behaviors included behaviors that occurred in the past month. The needle use score was a count of number of times they used a needle after someone else had used it (0 = none, 5 = more than 10 times), number of different people who used a needle before they had (0 = none, 5 = more than 10 times), number of times someone used a needle after they had (0 = none, 5 = more than 10 times), and before using needles how often they used bleach to clean the needles (0 = don't reuse, 5 = never). Scores could range from 0 to 20, and a higher score indicated a greater level of needle risky behaviors.
Time frame: Assessed at baseline and 3-month follow-up
Harm reduction risk behaviors included behaviors that occurred in the past month. The intercourse score was a count of the number of people a person had sex within the last month (0 = none, 5 = more than 10 people), the number of times a person used condoms when having sex with regular partner(s) in the last month (0 = no regular partner, 6 = never), how often they used condoms when they paid for sex (0 = not paid sex, 5 = never), how often they used condoms when having sex with casual partners (0 = no casual partners, 5 = never), and how many times they had anal sex in the last month (0 = 0 times, 5 = more than 5 times). Scores could range from 0 to 26, and a higher score indicated a greater level of intercourse risky behaviors.
University of Oregon
Other
Supported Employment to Create a Community Culture of COVID-19 Rapid Testing Among People Who Inject Drugs: PeerConnect2Test
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05760001
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06690554
Behavior, Disorders of Environmental Origin
Konya, Turkey (Türkiye)
View Trial DetailsNCT07566143
Adherence Interventions, Aging
Van, Turkey (Türkiye)
View Trial DetailsNCT06835920
Behavior, Health Behavior
Chapel Hill, North Carolina, United States
View Trial Details